# Genetic Research Domain Categories (DOMAINS.md)

## Overview
This document categorizes genetic research domains to facilitate systematic literature review organization. Each domain represents a distinct area of genetic research with specific methodologies, technologies, and clinical applications.

## Domain 1: Rare Disease Genetics

### Subcategories
- **Monogenic Disorders**: Single-gene disorders (e.g., cystic fibrosis, Huntington's disease)
- **Multifactorial Disorders**: Complex genetic contributions (e.g., diabetes, heart disease)
- **Chromosomal Abnormalities**: Structural and numerical chromosomal changes
- **Mitochondrial Disorders**: Maternally inherited genetic conditions

### Key Technologies
- Whole Exome Sequencing (WES)
- Whole Genome Sequencing (WGS)
- Chromosomal Microarray Analysis (CMA)
- Targeted Gene Panels

### Typical Metrics
- Disease penetrance (%)
- Allelic frequency
- Variant pathogenicity scores
- Diagnostic yield (%)

### Clinical Applications
- Diagnostic confirmation
- Genetic counseling
- Family planning
- Therapeutic selection

## Domain 2: Population Genetics and Genomics

### Subcategories
- **Population Structure**: Genetic variation across populations
- **Admixture Analysis**: Genetic ancestry and admixture patterns
- **Selection Signals**: Natural selection and adaptation
- **Demographic History**: Population migrations and bottlenecks

### Key Technologies
- SNP Arrays
- Whole Genome Sequencing
- Ancient DNA Analysis
- Epigenome-Wide Association Studies (EWAS)

### Typical Metrics
- FST values
- Linkage Disequilibrium (rÂ²)
- Effective population size (Ne)
- Migration rates

### Clinical Applications
- Ancestry inference
- Pharmacogenomics
- Disease risk stratification
- Personalized medicine

## Domain 3: Functional Genomics

### Subcategories
- **Transcriptomics**: RNA expression and regulation
- **Epigenomics**: DNA methylation, histone modifications
- **Proteomics**: Protein expression and function
- **Metabolomics**: Metabolic pathway analysis

### Key Technologies
- RNA Sequencing (RNA-seq)
- ATAC-seq (chromatin accessibility)
- ChIP-seq (protein-DNA interactions)
- Mass Spectrometry

### Typical Metrics
- Expression fold-change
- False Discovery Rate (FDR)
- Peak enrichment scores
- Pathway activity scores

### Clinical Applications
- Biomarker discovery
- Drug target identification
- Disease subtype classification
- Treatment response prediction

## Domain 4: Computational Genomics

### Subcategories
- **Variant Calling**: SNP/Indel identification
- **Structural Variation**: CNVs, translocations, inversions
- **Assembly**: De novo and reference-guided assembly
- **Annotation**: Functional impact prediction

### Key Technologies
- Sequence Aligners (BWA, Bowtie)
- Variant Callers (GATK, FreeBayes)
- Assembly Software (SPAdes, Canu)
- Annotation Tools (ANNOVAR, SnpEff)

### Typical Metrics
- Sensitivity/Specificity
- Positive/Negative Predictive Value
- Concordance rates
- Computational efficiency (runtime, memory)

### Clinical Applications
- Clinical variant interpretation
- Pipeline validation
- Quality control
- Automation and scaling

## Domain 5: Gene Therapy and Editing

### Subcategories
- **In Vivo Gene Therapy**: Direct therapeutic delivery
- **Ex Vivo Gene Therapy**: Cell-based therapeutic modification
- **Gene Editing**: CRISPR/Cas, TALENs, ZFNs
- **Epigenome Editing**: Targeted epigenetic modifications

### Key Technologies
- Viral Vectors (AAV, Lentivirus)
- Non-viral Delivery (Lipid nanoparticles)
- CRISPR Systems
- Base/Prime Editing

### Typical Metrics
- Editing efficiency (%)
- On-target vs Off-target ratio
- Therapeutic expression levels
- Safety markers

### Clinical Applications
- Treatment of monogenic disorders
- Cancer immunotherapy
- Regenerative medicine
- Prevention of inherited diseases

## Domain 6: Pharmacogenomics

### Subcategories
- **Drug Metabolism**: Enzyme activity and genetic variants
- **Drug Response**: Efficacy and adverse effects
- **Dosing Algorithms**: Personalized dosing based on genetics
- **Population-Specific Factors**: Ethnic differences in drug metabolism

### Key Technologies
- SNP Genotyping Arrays
- Targeted Sequencing
- Pharmacokinetic Modeling
- Clinical Decision Support Systems

### Typical Metrics
- Metabolic phenotype classification
- Dosing accuracy improvements
- Adverse event reduction (%)
- Cost-effectiveness ratios

### Clinical Applications
- Personalized drug selection
- Optimized dosing regimens
- Reduced adverse drug reactions
- Improved therapeutic outcomes

## Domain 7: Cancer Genomics

### Subcategories
- **Somatic Mutations**: Acquired mutations in tumors
- **Tumor Evolution**: Clonal dynamics and resistance
- **Liquid Biopsies**: Circulating tumor DNA analysis
- **Immuno-Oncology**: T-cell receptor and HLA analysis

### Key Technologies
- Tumor-Normal Sequencing
- Ultra-deep Sequencing
- Digital PCR
- Single-cell Sequencing

### Typical Metrics
- Tumor Mutation Burden (TMB)
- Microsatellite Instability (MSI)
- Circulating Tumor DNA (ctDNA) fraction
- Neoantigen load

### Clinical Applications
- Tumor profiling for targeted therapy
- Minimal residual disease detection
- Immunotherapy selection
- Resistance monitoring

## Cross-Domain Considerations

### Ethical Issues
- Privacy and data sharing
- Incidental findings
- Return of results
- Genetic discrimination

### Technical Challenges
- Data standardization
- Computational scalability
- Reproducibility
- Validation requirements

### Clinical Translation
- Regulatory pathways
- Clinical implementation
- Health economics
- Professional education

## Literature Organization Framework

When conducting a genetic literature review, consider organizing by:
1. Primary domain (most relevant to research question)
2. Technology platform (if technology-focused review)
3. Clinical application (if application-focused review)
4. Population studied (if population-specific review)
5. Temporal progression (chronological development of field)

This framework allows for flexible organization while maintaining scientific rigor and comprehensive coverage.